Credit Agricole S A Bellerophon Therapeutics, Inc. Transaction History

Credit Agricole S A

  • $18.2 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$9.43 - $20.28 $29,798 - $64,084
-3,160 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$3.39 - $18.0 $10,712 - $56,880
3,160 New
3,160 $35,000

Others Institutions Holding BLPH

# of Institutions
1
Shares Held
44K
Call Options Held
0
Put Options Held
0
View Full List

About Bellerophon Therapeutics, Inc.

BLPH Quotes by TradingView
  • Ticker BLPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,545,450
  • Market Cap $382K
  • Description
  • Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...
More about BLPH
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email